Shoulder Innovations Inc SI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Shoulder Innovations Reports Third Quarter 2026 Financial Results and Raises Full Year Outlook
Shoulder Innovations to Participate in Upcoming Investor Conferences
Shoulder Innovations to Report Third Quarter 2026 Financial Results on November 5, 2026
Shoulder Innovations Initiates Commercial Launch of the InSet® Go
Shoulder Innovations Gets FDA 510(k) Clearance for Shoulder Implant
Shoulder Innovations Receives FDA 510(k) Clearance for N-22 Humeral Head and Initiates Full Commercial Launch
Shoulder Innovations Announces Exclusive Partnership with ALM Ortho to Introduce Bespoke Solution for Complex Shoulder Reconstruction Procedures
Shoulder Innovations Announces Settlement of Patent Litigation with Catalyst OrthoScience
Trading Information
- Previous Close Price
- $20.54
- Day Range
- $19.27–21.84
- 52-Week Range
- $10.92–24.60
- Bid/Ask
- $14.00 / $25.88
- Shares Outstanding
- 20.92M
- Market Cap
- $448.99M
- Volume/Avg
- 245,843 / 118,002
Key Statistics
- Price/Earnings (Normalized)
- 16.43
- Price/Sales
- 6.90
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 0.50%
Company Profile
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System. Geographically, the company operates in United States and are planning to expand.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 75
Valuation
Metric | SI |
|---|---|
Price/Earnings (Normalized) | 16.43 |
Price/Book Value | 3.79 |
Price/Sales | 6.90 |
Price/Cash Flow | — |
Price/Earnings
SI
Financial Strength
Metric | SI |
|---|---|
Quick Ratio | 8.28 |
Current Ratio | 10.68 |
Interest Coverage | — |
Quick Ratio
SI
Profitability
Metric | SI |
|---|---|
Return on Assets (Normalized) | −18.30% |
Return on Equity (Normalized) | −22.20% |
Return on Invested Capital (Normalized) | −21.49% |
Return on Assets
SI
Medical Devices Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Abbott Laboratories ABT | LOCK|k@qhZp# | LOCK|fd%# | $191B | |||
| Medtronic PLC MDT | LOCK|d%?kbt$ | LOCK|>$#^ | $131B | |||
| Stryker Corp SYK | LOCK|Jlp<?>% | LOCK|@v | $124B | |||
| Boston Scientific Corp BSX | LOCK|ss@!RvR | LOCK|fyGy< | $64B | |||
| Edwards Lifesciences Corp EW | LOCK|>%Tz<Xb | LOCK|>f&^ | $60B | |||
| GE HealthCare Technologies Inc Common Stock GEHC | LOCK|bM<WH%^ | LOCK|?Fl | $38B | |||
| DexCom Inc DXCM | LOCK|S?z<dGf! | LOCK|K$ZP! | $30B | |||
| Koninklijke Philips NV ADR PHG | LOCK|@!% | LOCK|^Ww | $30B | |||
| Steris PLC STE | LOCK|lxVyk<! | LOCK|YVNxl | $25B | |||
| Zimmer Biomet Holdings Inc ZBH | LOCK|^?LBr?x | LOCK|WS | $21B |
United States